Setting

Global Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Region: Trend Forecast and Growth Opportunity

Published: 28 Jul 2020 | Report Code: 10247609 | Pages: 164

Global digital respiratory solutions market will reach $319.3 million by 2030, growing by 36.2% annually over 2020-2030 driven by the rising demand for air filtration amid COVID-19 pandemic. Highlighted with 84 tables and 76 figures, this 164-page report “Global Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Region. Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Therapeutic Devices • Inhalers • Nebulizers Diagnostic Devices • Spirometers • Asthma Monitors • Other Diagnostic Devices Sensors and Apps Based on Indication, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Asthma • Chronic Obstructive Pulmonary Disease (COPD) • COVID-19 Caused Diseases • Other Diseases Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • RoW (Saudi Arabia, UAE, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): 3M Health Care Limited Adherium Limited Amiko Digital Health Limited AsthmaMD AstraZeneca plc Boehringer Ingelheim International GmbH Capsule Technologies, Inc. Cohero Health GlaxoSmithKline plc Kaia Health Software GmbH Medical International Research (MIR) Novartis AG NuvoAir Reciprocal Labs (Propeller Health) Sensiron AG Tactio Health Teva Pharmaceuticals Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction 8 1.1 Industry Definition and Research Scope 8 1.1.1 Industry Definition 8 1.1.2 Research Scope 9 1.2 Research Methodology 12 1.2.1 Overview of Market Research Methodology 12 1.2.2 Market Assumption 13 1.2.3 Secondary Data 13 1.2.4 Primary Data 13 1.2.5 Data Filtration and Model Design 15 1.2.6 Market Size/Share Estimation 16 1.2.7 Research Limitations 17 1.3 Executive Summary 18 2 Market Overview and Dynamics 20 2.1 Market Size and Forecast 20 2.1.1 Impact of COVID-19 on the Market 21 2.2 Major Growth Drivers 23 2.3 Market Restraints and Challenges 28 2.4 Emerging Opportunities and Market Trends 31 2.5 Porter’s Fiver Forces Analysis 35 3 Segmentation of Global Market by Product Type 40 3.1 Market Overview by Product Type 40 3.2 Therapeutic Devices 42 3.2.1 Inhalers 43 3.2.2 Nebulizers 44 3.3 Diagnostic Devices 45 3.3.1 Spirometers 47 3.3.2 Asthma Monitors 48 3.3.3 Other Diagnostic Devices 49 3.4 Sensors and Apps 50 4 Segmentation of Global Market by Indication 51 4.1 Market Overview by Indication 51 4.2 Asthma 53 4.3 Chronic Obstructive Pulmonary Disease (COPD) 54 4.4 COVID-19 Caused Diseases 55 4.5 Other Diseases 56 5 Segmentation of Global Market by Distribution Channel 57 5.1 Market Overview by Distribution Channel 57 5.2 Hospital Pharmacies 59 5.3 Retail Pharmacies 60 5.4 Online Pharmacies 61 6 Segmentation of Global Market by Region 62 6.1 Geographic Market Overview 2019-2030 62 6.2 North America Market 2019-2030 by Country 68 6.2.1 Overview of North America Market 68 6.2.2 U.S. 72 6.2.3 Canada 76 6.2.4 Mexico 78 6.3 European Market 2019-2030 by Country 80 6.3.1 Overview of European Market 80 6.3.2 Germany 84 6.3.3 UK 86 6.3.4 France 88 6.3.5 Spain 90 6.3.6 Italy 92 6.3.7 Russia 94 6.3.8 Rest of European Market 96 6.4 Asia-Pacific Market 2019-2030 by Country 98 6.4.1 Overview of Asia-Pacific Market 98 6.4.2 Japan 102 6.4.3 China 105 6.4.4 Australia 108 6.4.5 India 110 6.4.6 South Korea 112 6.4.7 Rest of APAC Region 114 6.5 South America Market 2019-2030 by Country 116 6.5.1 Argentina 119 6.5.2 Brazil 121 6.5.3 Chile 123 6.5.4 Rest of South America Market 125 6.6 MEA Market 2019-2030 by Country 126 6.6.1 UAE 129 6.6.2 Saudi Arabia 131 6.6.3 South Africa 133 6.6.4 Other National Markets 135 7 Competitive Landscape 136 7.1 Overview of Key Vendors 136 7.2 New Product Launch, Partnership, Investment, and M&A 139 7.3 Company Profiles 140 3M Health Care Limited 140 Adherium Limited 142 Amiko Digital Health Limited 143 AsthmaMD 144 AstraZeneca plc 145 Boehringer Ingelheim International GmbH 146 Capsule Technologies, Inc. 147 Cohero Health 148 GlaxoSmithKline plc 149 Kaia Health Software GmbH 150 Medical International Research (MIR) 151 Novartis AG 152 NuvoAir 153 Reciprocal Labs (Propeller Health) 154 Sensiron AG 155 Tactio Health 156 Teva Pharmaceuticals Industries Ltd. 157 8 Investing in Global Market: Risk Assessment and Management 158 8.1 Risk Evaluation of Global Market 158 8.2 Critical Success Factors (CSFs) 161 Related Reports and Products 164
List Of Tables

Table 1. Snapshot of Global Digital Respiratory Solutions Market, 2019-2030 19 Table 2. Main Product Trends and Market Opportunities in Global Digital Respiratory Solutions Market 31 Table 3. Global Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 40 Table 4. Global Digital Respiratory Solutions Market: Therapeutic Devices by Type, 2019-2030, $ mn 42 Table 5. Global Digital Respiratory Solutions Market: Diagnostic Devices by Type, 2019-2030, $ mn 46 Table 6. Global Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 51 Table 7. Global Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 57 Table 8. Global Digital Respiratory Solutions Market by Region, 2019-2030, $ mn 63 Table 9. Total Health Expenditure per capita in PPP International U.S. Dollars by Country 65 Table 10. Leading National Digital Respiratory Solutions Market, 2019 and 2030, $ mn 67 Table 11. North America Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 70 Table 12. U.S. Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 74 Table 13. U.S. Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 74 Table 14. U.S. Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 74 Table 15. Canada Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 77 Table 16. Canada Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 77 Table 17. Canada Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 77 Table 18. Mexico Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 79 Table 19. Mexico Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 79 Table 20. Mexico Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 79 Table 21. Europe Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 83 Table 22. Germany Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 85 Table 23. Germany Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 85 Table 24. Germany Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 85 Table 25. UK Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 87 Table 26. UK Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 87 Table 27. UK Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 87 Table 28. France Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 89 Table 29. France Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 89 Table 30. France Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 89 Table 31. Spain Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 91 Table 32. Spain Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 91 Table 33. Spain Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 91 Table 34. Italy Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 93 Table 35. Italy Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 93 Table 36. Italy Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 93 Table 37. Russia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 95 Table 38. Russia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 95 Table 39. Russia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 95 Table 40. Digital Respiratory Solutions Market in Rest of Europe by Country, 2019-2030, $ mn 97 Table 41. APAC Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 100 Table 42. Japan Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 104 Table 43. Japan Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 104 Table 44. Japan Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 104 Table 45. China Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 107 Table 46. China Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 107 Table 47. China Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 107 Table 48. Australia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 109 Table 49. Australia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 109 Table 50. Australia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 109 Table 51. India Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 111 Table 52. India Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 111 Table 53. India Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 111 Table 54. South Korea Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 113 Table 55. South Korea Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 113 Table 56. South Korea Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 113 Table 57. Digital Respiratory Solutions Market in Rest of APAC by Country, 2019-2030, $ mn 115 Table 58. South America Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 118 Table 59. Argentina Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 120 Table 60. Argentina Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 120 Table 61. Argentina Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 120 Table 62. Brazil Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 122 Table 63. Brazil Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 122 Table 64. Brazil Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 122 Table 65. Chile Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 124 Table 66. Chile Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 124 Table 67. Chile Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 124 Table 68. MEA Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 128 Table 69. UAE Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 130 Table 70. UAE Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 130 Table 71. UAE Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 130 Table 72. Saudi Arabia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 132 Table 73. Saudi Arabia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 132 Table 74. Saudi Arabia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 132 Table 75. South Africa Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 134 Table 76. South Africa Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 134 Table 77. South Africa Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 134 Table 78. 3M Health Care Limited: Company Snapshot 140 Table 79. 3M Health Care Limited: Business Segmentation 140 Table 80. 3M Health Care Limited: Product Portfolio 141 Table 81. 3M Health Care Limited: Revenue, 2016-2018, $ mn 141 Table 82. 3M Health Care Limited: Recent Developments 141 Table 83. Risk Evaluation for Investing in Global Market, 2019-2030 159 Table 84. Critical Success Factors and Key Takeaways 162
List Of Figures

Figure 1. Research Method Flow Chart 12 Figure 2. Breakdown of Primary Research 14 Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 16 Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 18 Figure 5. Global Digital Respiratory Solutions Market, 2019-2030, $ mn 20 Figure 6. Primary Drivers and Impact Factors of Global Digital Respiratory Solutions Market 23 Figure 7. GDP per capita in the World, 1960-2018, $ thousand 26 Figure 8. Forecast of Middle-class Population by Region, 2015-2030, million 26 Figure 9. Worldwide Connected Devices by Device Type, 2014-2022, billion units 27 Figure 10. Primary Restraints and Impact Factors of Global Digital Respiratory Solutions Market 28 Figure 11. Investment Opportunity Analysis 32 Figure 12. Porter’s Fiver Forces Analysis of Global Digital Respiratory Solutions Market 35 Figure 13. Breakdown of Global Digital Respiratory Solutions Market by Product Type, 2019-2030, % of Sales Revenue 40 Figure 14. Global Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%) 41 Figure 15. Global Digital Respiratory Solutions Market: Therapeutic Devices, 2019-2030, $ mn 42 Figure 16. Global Digital Respiratory Solutions Market: Inhalers, 2019-2030, $ mn 43 Figure 17. Global Digital Respiratory Solutions Market: Nebulizers, 2019-2030, $ mn 44 Figure 18. Global Digital Respiratory Solutions Market: Diagnostic Devices, 2019-2030, $ mn 45 Figure 19. Global Digital Respiratory Solutions Market: Spirometers, 2019-2030, $ mn 47 Figure 20. Global Digital Respiratory Solutions Market: Asthma Monitors, 2019-2030, $ mn 48 Figure 21. Global Digital Respiratory Solutions Market: Other Diagnostic Devices, 2019-2030, $ mn 49 Figure 22. Global Digital Respiratory Solutions Market: Sensors and Apps, 2019-2030, $ mn 50 Figure 23. Breakdown of Global Digital Respiratory Solutions Market by Indication, 2019-2030, % of Sales Revenue 52 Figure 24. Global Addressable Market Cap in 2020-2030 by Indication, Value ($ mn) and Share (%) 52 Figure 25. Global Digital Respiratory Solutions Market: Asthma, 2019-2030, $ mn 53 Figure 26. Global Digital Respiratory Solutions Market: Chronic Obstructive Pulmonary Disease (COPD), 2019-2030, $ mn 54 Figure 27. Global Digital Respiratory Solutions Market: COVID-19 Caused Diseases, 2019-2030, $ mn 55 Figure 28. Global Digital Respiratory Solutions Market: Other Diseases, 2019-2030, $ mn 56 Figure 29. Breakdown of Global Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, % of Revenue 58 Figure 30. Global Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%) 58 Figure 31. Global Digital Respiratory Solutions Market: Hospital Pharmacies, 2019-2030, $ mn 59 Figure 32. Global Digital Respiratory Solutions Market: Retail Pharmacies, 2019-2030, $ mn 60 Figure 33. Global Digital Respiratory Solutions Market: Online Pharmacies, 2019-2030, $ mn 61 Figure 34. Global Market Snapshot by Region 62 Figure 35. Geographic Spread of Worldwide Digital Respiratory Solutions Market, 2019-2030, % of Sales Revenue 63 Figure 36. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%) 64 Figure 37. Health Spending as a Share of GDP by Country, 2015 and 2030 66 Figure 38. North American Digital Respiratory Solutions Market, 2019-2030, $ mn 69 Figure 39. Breakdown of North America Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 70 Figure 40. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 71 Figure 41. U.S. Digital Respiratory Solutions Market, 2019-2030, $ mn 73 Figure 42. Canada Digital Respiratory Solutions Market, 2019-2030, $ mn 76 Figure 43. Digital Respiratory Solutions Market in Mexico, 2015-2030, $ mn 78 Figure 44. European Digital Respiratory Solutions Market, 2019-2030, $ mn 81 Figure 45. Breakdown of European Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 82 Figure 46. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 83 Figure 47. Digital Respiratory Solutions Market in Germany, 2019-2030, $ mn 84 Figure 48. Digital Respiratory Solutions Market in UK, 2019-2030, $ mn 86 Figure 49. Digital Respiratory Solutions Market in France, 2019-2030, $ mn 88 Figure 50. Digital Respiratory Solutions Market in Spain, 2019-2030, $ mn 90 Figure 51. Digital Respiratory Solutions Market in Italy, 2019-2030, $ mn 92 Figure 52. Digital Respiratory Solutions Market in Russia, 2019-2030, $ mn 94 Figure 53. Digital Respiratory Solutions Market in Rest of Europe, 2019-2030, $ mn 96 Figure 54. Asia-Pacific Digital Respiratory Solutions Market, 2019-2030, $ mn 99 Figure 55. Breakdown of APAC Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 99 Figure 56. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 101 Figure 57. Digital Respiratory Solutions Market in Japan, 2019-2030, $ mn 103 Figure 58. Digital Respiratory Solutions Market in China, 2019-2030, $ mn 106 Figure 59. Digital Respiratory Solutions Market in Australia, 2019-2030, $ mn 108 Figure 60. Digital Respiratory Solutions Market in India, 2019-2030, $ mn 110 Figure 61. Digital Respiratory Solutions Market in South Korea, 2019-2030, $ mn 112 Figure 62. Digital Respiratory Solutions Market in Rest of APAC, 2019-2030, $ mn 114 Figure 63. South America Digital Respiratory Solutions Market, 2019-2030, $ mn 117 Figure 64. Breakdown of South America Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 117 Figure 65. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 118 Figure 66. Digital Respiratory Solutions Market in Argentina, 2019-2030, $ mn 119 Figure 67. Digital Respiratory Solutions Market in Brazil, 2019-2030, $ mn 121 Figure 68. Digital Respiratory Solutions Market in Chile, 2019-2030, $ mn 123 Figure 69. Digital Respiratory Solutions Market in Rest of South America, 2019-2030, $ mn 125 Figure 70. Digital Respiratory Solutions Market in MEA, 2019-2030, $ mn 127 Figure 71. Breakdown of MEA Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 127 Figure 72. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 128 Figure 73. Digital Respiratory Solutions Market in UAE, 2019-2030, $ mn 129 Figure 74. Digital Respiratory Solutions Market in Saudi Arabia, 2019-2030, $ mn 131 Figure 75. Digital Respiratory Solutions Market in South Africa, 2019-2030, $ mn 133 Figure 76. Growth Stage of Global Digital Respiratory Solutions Industry over the Forecast Period 136
Key Players (this may not be a complete list and extra companies can be added upon request): 
3M Health Care Limited 
Adherium Limited 
Amiko Digital Health Limited 
AsthmaMD 
AstraZeneca plc 
Boehringer Ingelheim International GmbH 
Capsule Technologies, Inc. 
Cohero Health 
GlaxoSmithKline plc 
Kaia Health Software GmbH 
Medical International Research (MIR) 
Novartis AG 
NuvoAir 
Reciprocal Labs (Propeller Health) 
Sensiron AG 
Tactio Health 
Teva Pharmaceuticals Industries Ltd.